Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
AFTER logo

The AFTER (Ankle Fracture Treatment: Enhancing Rehabilitation) project is a NIHR funded four year programme of work that is aiming to refine and assess different approaches to providing physiotherapy after an ankle fracture for adults aged 50 years or over.

Interested in getting involved?

The AFTER Programme team are currently organising the an Intervention Development Meeting to be held in Oxford on Friday 24th November.  The meeting will involve patient and public representatives and health professionals to help with the process of developing the physiotherapy treatments to be assessed in a feasibility randomised controlled trial. To find out more about this meeting, please contact the programme's Chief Investigator David Keene (david.keene@ndorms.ox.ac.uk tel. 01865 223121). 

For more information on AFTER, please visit the web page here.

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.